Species | Target name | Source | Bibliographic reference |
---|---|---|---|
SARS coronavirus | SARS coronavirus 3C-like proteinase | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 270 nM | Inhibition of SARS coronavirus 3C-like protease | ChEMBL. | 17381079 |
IC50 (binding) | = 270 nM | Inhibition of SARS coronavirus 3C-like protease | ChEMBL. | 17381079 |
Inhibition (binding) | = 98 % | Inhibition of SARS coronavirus 3C-like protease at 1 uM | ChEMBL. | 17381079 |
Inhibition (binding) | = 98 % | Inhibition of SARS coronavirus 3C-like protease at 1 uM | ChEMBL. | 17381079 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.